Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Total article views   Abstract views HTML views PDF downloads Totals
7,281 Dovepress* 5,511 702+ 877 6,213
PubMed Central* 0 1,068 313 1,068
Totals 5,511 1,770 1,190 7,281
*Since 12 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar